• BAPINEUZUMAB chembl:CHEMBL2108576

    Alternate Names:

    HUMANIZED 3D-6 MONOCLONAL ANTIBODY
    AAB-001, HUMANIZED 3D-6 MONOCLONAL ANTIBODY
    BAPINEUZUMAB
    3D-6
    AAB-001

    Drug Info:

    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications for treatment of alzheimer's disease
    (0 More Sources)

    Publications:

  • Interaction Score: 5.98

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name Bapineuzumab
    Novel drug target Novel Target
    Mechanism of Interaction Beta amyloid A4 protein other

    PMIDs:
    None found